SG Americas Securities
ACET icon

SG Americas Securities’s Adicet Bio ACET Stock Holding History

SG Americas Securities’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-948
Closed -$18K – 3396
2024
Q2 		$18K Sell
948
-207
-18% -$5.55K ﹤0.01% 2761
2024
Q1 		$43K Buy
1,155
+155
+16% +$6.41K ﹤0.01% 2787
2023
Q4 		$30K Buy
1,000
+174
+21% +$3.79K ﹤0.01% 2985
2023
Q3 		$18K Buy
+826
New +$29.2K ﹤0.01% 3050
2023
Q2 		– Sell
-802
Closed -$74K – 2222
2023
Q1 		$74K Buy
802
+118
+17% +$14.8K ﹤0.01% 2993
2022
Q4 		$98K Sell
684
-192
-22% -$47.9K ﹤0.01% 2728
2022
Q3 		$199K Buy
876
+189
+28% +$48K ﹤0.01% 2321
2022
Q2 		$160K Buy
+687
New +$151K ﹤0.01% 2820
2021
Q4 		– Sell
-916
Closed -$115K – 3333
2021
Q3 		$115K Buy
+916
New +$114K ﹤0.01% 3597

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

SG Americas Securities's ACET Position: Q3 2024 in Review

SG Americas Securities sold out of Adicet Bio (ACET) in Q3 2024, closing a stake of 948 shares — an estimated $18K sold.

SG Americas Securities first reported a position in ACET in Q3 2021 and held it in 9 quarters. The position peaked at $199K in Q3 2022. 64 funds tracked by Wall St. Rank hold ACET as of Q3 2024.

  • SG Americas Securities reported no remaining Adicet Bio position as of Q3 2024 after selling out during the quarter.
  • SG Americas Securities sold 948 Adicet Bio shares in Q3 2024, an estimated $18K.
  • SG Americas Securities first reported a position in Adicet Bio in Q3 2021 and held it in 9 quarters.
  • SG Americas Securities's Adicet Bio position peaked at $199K in Q3 2022.
  • 64 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2024.

Based on SG Americas Securities's 13F filing for Q3 2024, filed 3 Oct 2024.